Danaher Corporation $DHR Stock Purchased by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC grew its stake in shares of Danaher Corporation (NYSE:DHR) by 44.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,199 shares of the conglomerate’s stock after buying an additional 6,259 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in Danaher were worth $4,475,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. BlackRock Inc. purchased a new stake in Danaher during the 2nd quarter valued at about $10,492,520,000. Wellington Management Group LLP grew its position in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after acquiring an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC bought a new position in Danaher during the 2nd quarter worth approximately $1,456,317,000. Generation Investment Management LLP bought a new position in Danaher during the 2nd quarter worth approximately $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in Danaher in the 2nd quarter worth approximately $993,846,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE:DHR opened at $228.87 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $214.04 and a 200-day moving average price of $195.97. The company has a market cap of $160.89 billion, a price-to-earnings ratio of 40.65, a price-to-earnings-growth ratio of 2.88 and a beta of 0.76. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.77 earnings per share. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio is presently 28.42%.

Analyst Ratings Changes

Several analysts have weighed in on the company. Evercore reiterated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. The Goldman Sachs Group increased their price objective on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Royal Bank Of Canada raised their target price on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Wells Fargo & Company cut their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Finally, Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $235.41.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.